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Abstract
Background: Xenologous or synthetic graft materials are commonly used as an alternative for autografts for
guided bone regeneration. The purpose of this study was to evaluate effectiveness of carbonate apatite on
the critical-size bone defect of rat’s calvarium.
Methods: Thirty-six critical-size defects were created on 18 adult male Sprague-Dawley rat calvaria under general
anesthesia. Calvarial bones were grinded with 8 mm in daimeter bilaterally and then filled with (1) no grafts (control,
n = 10 defects), (2) bovine bone mineral (Bio-Oss®, Geistlich Pharma Ag. Swiss, n = 11 defects), and (3) hydroxyapatite
(Bongros®, Bio@ Inc., Seongnam, Korea, n = 15 defects). At 4 and 8 weeks after surgery, the rats were sacrificed and all
samples were processed for histological and histomorphometric analysis.
Results: At 4 weeks after surgery, group 3 (42.90 ± 9.33 %) showed a significant difference (p < 0.05) compared to
the control (30.50 ± 6.05 %) and group 2 (28.53 ± 8.62 %). At 8 weeks after surgery, group 1 (50.21 ± 6.23 %), group 2
(54.12 ± 10.54 %), and group 3 (50.92 ± 6.05 %) showed no significant difference in the new bone formation.
Conclusions: Bongros®-HA was thought to be the available material for regenerating the new bone formation.
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Background
Various bone graft materials provide osteoconductive
matrix to enhance the rate and quality of bone for-
mation in hard tissue-defected region [1]. For the re-
construction of bone defect, autologous bone graft is
recommended primarily due to osteogenic, osteoin-
ductive, and osteoconductive properties [2]. However,
autograft is often associated with complications at the
harvesting site and limited in quantity [3]. Allograft
or xenograft is the most commonly used alternative
for autogenous harvest, but these materials have a po-
tential risk of disease transmission, rejection, infec-
tion, and resorption [4].
Critical-size defect (CSD) is defined as the smallest
diameter osseous defect that does not heal spontan-
eously. Conflicting results have been reported regarding
the suitable size of CSD for evaluation of bone regen-
erative materials in rat calvarial defect model. A full-
thickness 8-mm-diameter defect has been suggested as
a CSD in rat calvaria [5, 6]. Bilateral calvarial defect has
been widely used as a convenient model for testing
osteoconductive properties of bone substitutes due to
easy handling and low morbidity by reducing the risk of
damage in the superior sagittal sinus [7, 8].
Bone apatite is not pure hydroxyapatite (HAp,
Ca10((PO4)6OH2)). It contains approximately 6 weight %
(wt%) of carbonate ions (CO3
2−) as well as other trace el-
ements such as Mg2+, Fe2+, Na+, HPO4
2−, F−, and CI− [9].
In terms of its chemical properties, carbonate-containing
apatite resembles bone apatite more than pure HAp
[10]. HAp has been widely used as a bone substitute
because of its excellent biocompatibility and osteocon-
ductive ability. However, its clinical application may be
limited because it seems to be not appreciably resorbed
[11]. In fact, bioceramics are made of HAp and beta tri-
calcium phosphate (ß-TCP) and these mixtures have
demonstrated bioactivity and osteoconductivity [12].
Past in vivo and in vitro studies have suggested that
various autocrine and/or paracrine growth factors in the
serum play important roles in wound healing of various
tissues, including bone [13]. These growth factors appear
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to stimulate early phases of wound healing, cell differen-
tiation, and increased primary matrix production, rather
than remodeling and maturation processes [14].
This study was performed to evaluate new bone for-
mation in critical-size defects filled with hydroxyapatite




Eighteen adult male Sprague-Dawley rats (each weighing
approximately 0.40 kg) were used in this study. The rats
were housed in standard cages and were fed under stand-
ard laboratory diet. All animal handling and surgical pro-
cedures were performed according to the animal care
guideline and use of laboratory animals. This experiment
was approved by the Chosun University Institutional
Animal Care and Use Committee, Gwangju, South Korea
(CIACUC2014-A0027).
Surgical procedure
General anesthesia was induced by intramuscular injec-
tion with 0.5 mg/kg of a combination of Zoletil®50 (tileta-
mine + zolazepam 1:1; Virbac S.A., Carros, France) and
Rompun (xylazine; Bayer Healthcare Korea, Korea) in a
ratio of 1:1. After shaving and painting with povidone-
iodine, local anesthesia was treated with 2 % lidocaine
(Yuhan Co., Seoul, Korea) with 1/100,000 epinephrine. A
mid-sagittal incision was performed for exposure of
parietal bones. Using a diamond bur, two critical-sized
defects (each diameter ≥8 mm) were created in both sides
of the parietal bone under normal saline irrigation (Fig. 1).
The defects were filled with the following: (1) group 1: no
graft as control group (n = 10 defects); (2) group 2:
Bio-Oss® (Geistlich Pharma Ag., Swiss, n = 11 defects);
and (3) group 3: Bongros® (Bio@ Inc., Seongnam, Korea,
n = 15 defects) were used by mixing with saline solution
to fill one defect each. The wounds were sutured with
Vicryl 4-0 (Ethicon Inc., GA, USA). All the animals re-
ceived a single intramuscular injection with 0.1 ml/kg of
Fig. 1 Two defects (diameter ≥8 mm) were created. Bone graft materials were filled in the critical-size defects
Fig. 2 Determination of the bone regeneration. The average fraction of bone regeneration from each group was determined to be the average
fraction of bone regeneration: Fraction of bone regeneration = (An/Ad) × 100(%) (Ad: the area of the original defect; An: the area of the
newly formed bone within the defect). First, the assessment of bone healing was performed in each portion and the two portions were
summarized by the following formula to evaluate the fraction of bone healing at the whole defect site: The fraction of bone regeneration = (Aln + Acn)/
(Ald + Acd) × 100(%) (Ald : the original defect at the lateral portion; Acd : original defect at the central portion; Aln: the area of the newly formed bone
within the lateral portion defect; Acn: the area of the newly formed bone within the central portion defect)
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antibiotics (gentamicin, Daesung Microbiological Labs.
Co. Ltd., Seoul, Korea) for 3 days.
Histologic and histomorphometric analysis
Histologic analysis
The animals were sacrificed at 4 and 8 weeks after sur-
gery. Histologic samples were harvested including graft
sites. The samples were fixed in 10 % neutral-buffered
formalin for 3 days and then decalcified in 12.5 % EDTA
(Sigma-Aldrich) pH 7.0 for an additional 15 ± 3 days.
The samples were serially dehydrated in ethanol in a tis-
sue processor (Shandon Citadel 1000, Thermo Scientific,
Franklin, MA, USA) and embedded with paraffin (Leica
EG 160). Sections of 5-μm thickness were taken using a
microtome (Leica RM 2135). The slides were deparaffi-
nized with xylene and rehydrated with serial concentra-
tions of ethanol.
The slides were stained with hematoxylin-eosin
(Sigma-Aldrich) for the use of optical microscope. Using
optical microscope, the sections were examined for
evaluation of bone formation and integration of the re-
constructed areas into the neighboring bone tissue.
Histomorphometric analysis
Using optical microscope (Primo Star, Carl Zeiss Co., Ltd.,
Germany) and imaging software (AxioVision 4.7.2),
images were obtained for morphology and for analyzing
fraction of bone healing. All images were transferred from
AxioVision to Adobe Photoshop Elements 7.0 software.
Histomorphometric assessment was performed by an in-
dividual who was blind to the treatments. The area of the
defect and the newly formed bone was measured using
Adobe Photoshop Elements 7.0 software. These measure-
ments were used in the following formula to determine
the fraction of bone regeneration. The average fraction of
bone regeneration from each group was determined to be
the average fraction of bone regeneration:
Fraction of bone regeneration ¼ An=Adð Þ  100 %ð Þ
where Ad is the area of the original defect and An is
the area of the newly formed bone within the defect
site (Fig. 2).
Because bone regeneration was processed from the
edge of the defect and towards the center of the de-
fect, two portions (lateral and central portions) of the
defect were used. First, the assessment of bone heal-
ing was performed for each portion, and then, the
two portions were summarized by the following for-
mula to evaluate the fraction of bone healing at the
whole defect site:
Fig. 3 The newly formed bone in the central portion at 4 weeks after treatment: group 1 (a), group 2 (b), and group 3 (c)
Fig. 4 The newly formed bone in the lateral portion at 4 weeks after treatment: group 1 (a), group 2 (b), and group 3 (c)
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The fraction of bone regeneration
¼ Aln þ Acnð Þ= Ald þ Acdð Þ  100 %ð Þ
where Ald is the area of the original defect in the lateral
portion, Acd is the area of the original defect in the cen-
tral portion, Aln is the area of the newly formed bone
within the lateral portion of the defect, and Acn is the
area of the newly formed bone within the central portion
of the defect.
Statistical analysis
All data were expressed as mean and standard deviation.
The new bone formation rate was analyzed via one-way
ANOVA and post hoc test.
Results
After surgery, no visible complication was seen in any
rats and wounds.
Histologic findings
During the process of paraffin embedding, the scaffold
composed of bone graft materials was dissolved and the
space was represented as empty. And new bone forma-
tion was first detected as clusters of globular structures.
In the central portion at 4 weeks (Fig. 3), group 1
(control, Fig. 3a) seemed to have less newly formed
bone and connective tissue compared to group 2
(Fig. 3b) and group 3 (Fig. 3c). However, half of the
defect was filled with the newly formed bone in the
lateral portion of group 3(Fig. 4c) at 4 weeks, and the
amount of the newly formed bone was similar to that
of native bone.
In the central portion at 8 weeks (Fig. 5), the amount
of the newly formed bone was similar to all groups. In
the lateral portion at 8 weeks (Fig. 6), the amount of the
newly formed bone was similar in all groups except the
control group (Fig 6a).
Histomorphometric analysis
At 4 weeks after surgery, group 3 (42.90 ± 9.33 %) showed
a significant difference (p < 0.05) compared to the control
(30.50 ± 6.05 %) and group 2 (28.53 ± 8.62 %) (Table 1).
At 8 weeks after surgery, group 1 (50.21 ± 6.23 %), group
2 (54.12 ± 10.54 %), and group 3 (50.92 ± 6.05 %) showed
no significant difference in new bone formation (Table 2).
In detail, new bone formation was analyzed in two
portions—central and lateral. The lateral portion seemed
to show higher bone regeneration than the central por-
tion. At 4 weeks in the lateral portion, group 3 (63.99 ±
9.14 %) showed a significantly higher amount of bone
formation (p < 0.05) compared to other groups. In the
Fig. 5 The newly formed bone in the central portion at 8 weeks after treatment: group 1 (a), group 2 (b), and group 3 (c)
Fig. 6 The newly formed bone in the lateral portion at 8 weeks after treatment: group 1 (a), group 2 (b), and group 3 (c)
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central portion at 4 weeks, group 2 and group 3 showed
similar new bone formation compared to the control
group. At 8 weeks in the lateral portion, all groups
showed similar value of new bone formation. At 8 weeks
in the central portion, all groups showed similar value of
new bone formation.
In summary, group 3 (Bongros) showed significant
difference compared to the control (group 1) and
group 2 (Bio-Oss) in new bone formation at 4 weeks
after surgery, especially the lateral portion of defect.
At 8 weeks after surgery, there were no differences
among groups 1, 2, and 3.
Discussion
Critical-size defect (CSD) is defined as the smallest
diameter osseous defect that does not heal spontan-
eously. A full-thickness 8-mm-diameter defect has been
suggested as a CSD in rat calvaria [5, 6]. However, sev-
eral experimental studies have suggested that non-CSD
may also be meaningful, in which commercially available
bone substitutes showed no osteoconductive properties
nor impeded new bone formation in rat calvarial defects
[15, 16]. Other studies have reported that 5- or 6-mm-
diameter defects also fulfill the requirements of a CSD
in rat calvaria [7, 8, 17]. However, Park et al. [18] re-
ported that a 5-mm-diameter calvarial defect is not a
CSD in rats because unfilled defects achieved a high de-
gree of new bone formation at 8 weeks. Based on these
review of literatures, 8-mm diameter was formed as a
CSD in the rat calvaria in this study for strict
examination.
HAp has a few disadvantages such as slow absorp-
tion rate and low solubility due to low component of
carbonate (whereas natural bone has 2.3–8 %/g of
carbonate) [19]. Substitution of the functional struc-
tures, OH− or PO4
−, of HAp to CO3
− improves these
disadvantages [20, 21].
HAp ceramics have good biocompatibility and
osteoinductivity, but no osteogenecity [22]. Various
products made by HAp seems to have different
osteoinductivities [23], in which one of the reason is
porous structures, the degree of interconnection be-
tween pores and interconnected pore size [24]. When
the interconnected pore size was over 100 μm, osteo-
cytes can differentiate by sufficient nutrition via
angiogenesis [24, 25]. However, the optimal size was
reported to be 300 μm in literatures, and the bone
growth can be inhibited when interconnected pores
are too large [26]. Bongros® used in this study has a
pore size of 300 μm.
The anorganic bone derived from bovine has reported
satisfactory results in various cases of clinical and animal
studies for many years, but the range of new bone for-
mation was shown in large variations (5–42 %) [27, 28].
Jensen et al. [27] reported that new bone formation oc-
cupied 4 % (2 weeks), 26 % (4 weeks), and 42 %(8 weeks)
in the mandibular angle of minipigs. The proportion was
lower than that of autogenous bone or tricalcium phos-
phate (TCP) but was regarded as a favorable result. Kim
et al. [29] also reported that new bone formation was
more vigorous in the HAp group than in the bovine
bone mineral group. However, between the HAp group
and the bovine bone mineral group, there is no signifi-
cant difference of quantity of the newly formed bone in
this study.
Conclusions
The purpose of this study was to evaluate new bone for-
mation in rat calvarial critical-sized bone defects. HAp
united bone tissue and provided effective space to make
new bone ingrowth, and it was similar to the effect of
new bone formation with Bio-Oss. Bongros® was thought
to be the available material for regenerating the new
bone formation as a scaffold.
Table 1 Histomorphometric analysis at 4 weeks after surgery
Number New bone formation rate (mean ± SD(%)) Central portion (mean ± SD(%)) Lateral portion (mean ± SD(%))
Group 1 (control) 4 30.50 ± 6.05 21.08 ± 3.45 40.48 ± 15.58
Group 2 (Bio-Oss®) 4 28.53 ± 8.62 13.53 ± 6.25 49.08 ± 16.44
Group 3 (Bongros®) 7 42.90 ± 9.33* 24.56 ± 9.08 63.99 ± 9.14*
*Statistically significant at 0.05 level
Table 2 Histomorphometric analysis at 8 weeks after surgery
Number New bone formation rate (mean ± SD(%)) Central portion (mean ± SD(%)) Lateral portion (mean ± SD(%))
Group 1 (control) 6 50.21 ± 6.23 28.88 ± 17.29 74.47 ± 12.73
Group 2 (Bio-Oss®) 7 54.12 ± 10.54 25.70 ± 17.23 81.56 ± 7.30
Group 3 (Bongros®) 8 50.92 ± 6.05 36.44 ± 9.52 65.34 ± 11.48
Statistically significant at 0.05 level
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